Hunan Jiudian Pharmaceutical Co., Ltd. (SHE:300705)
China · Delayed Price · Currency is CNY 11.78
-0.34 (-2.81%)
May 20, 2026, 1:45 PM CST
SHE:300705 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Net Income | 403.78 | 472.82 | 512.38 | 368.26 | 269.7 | 204.25 |
Depreciation & Amortization | 120.66 | 120.66 | 94.97 | 71.48 | 59.7 | 53.58 |
Other Amortization | 5.4 | 5.4 | 1.66 | 1.28 | 1.04 | 1.03 |
Loss (Gain) From Sale of Assets | -0.05 | -0.05 | - | -0.03 | - | -0.02 |
Asset Writedown & Restructuring Costs | 4.22 | 4.22 | 1.92 | 1.46 | 0.39 | 0.88 |
Loss (Gain) From Sale of Investments | 0.96 | 0.96 | -3.11 | -2.13 | -1.84 | -2.85 |
Provision & Write-off of Bad Debts | 0.72 | 0.72 | -3.93 | 7.59 | 12.77 | 5.36 |
Other Operating Activities | 43.39 | 43.78 | 25.81 | 18.27 | 24.37 | 31.78 |
Change in Accounts Receivable | -27.8 | -27.8 | 137.01 | -125.79 | -224.11 | -115.63 |
Change in Inventory | 31.59 | 31.59 | -91.25 | -24.06 | -32.1 | -76.92 |
Change in Accounts Payable | 9.43 | 9.43 | 48.91 | 112.06 | 138.62 | 100.75 |
Change in Other Net Operating Assets | -12.34 | -12.34 | 4.86 | 26.96 | 28.93 | - |
Operating Cash Flow | 577.63 | 647.06 | 746.36 | 431.19 | 268.99 | 190.87 |
Operating Cash Flow Growth | -11.88% | -13.30% | 73.10% | 60.30% | 40.93% | 27.25% |
Capital Expenditures | -642.6 | -652.89 | -397.87 | -426.82 | -413.38 | -125.93 |
Sale of Property, Plant & Equipment | 0.5 | 0.5 | 0.12 | 0.15 | 0.13 | 0.27 |
Cash Acquisitions | -8.34 | -8.34 | - | - | - | -6.43 |
Investment in Securities | -13.2 | 24.8 | -257.12 | - | -20 | -100 |
Other Investing Activities | 3.35 | 2.72 | 3.27 | 2.1 | 1.9 | 2.54 |
Investing Cash Flow | -660.3 | -633.21 | -651.6 | -424.58 | -431.35 | -229.56 |
Long-Term Debt Issued | - | 226.53 | 81.4 | 157.8 | 314.76 | 53.7 |
Total Debt Issued | 216.3 | 226.53 | 81.4 | 157.8 | 314.76 | 53.7 |
Long-Term Debt Repaid | - | -11.73 | -61.31 | -364.09 | -124.44 | -17.75 |
Total Debt Repaid | -15.76 | -11.73 | -61.31 | -364.09 | -124.44 | -17.75 |
Net Debt Issued (Repaid) | 200.54 | 214.8 | 20.09 | -206.29 | 190.32 | 35.95 |
Issuance of Common Stock | 25.64 | 25.64 | 19.17 | 381.06 | - | 270 |
Repurchase of Common Stock | -100.05 | -100.05 | - | - | - | - |
Common Dividends Paid | -162.13 | -160.92 | -115.71 | -94.62 | -69.3 | -15.01 |
Dividends Paid | -162.13 | -160.92 | -115.71 | -94.62 | -69.3 | -15.01 |
Other Financing Activities | 30.26 | 25.42 | - | -6.61 | - | -7.38 |
Financing Cash Flow | -5.73 | 4.89 | -76.45 | 73.55 | 121.02 | 283.56 |
Foreign Exchange Rate Adjustments | -0.1 | -0.06 | - | - | - | - |
Net Cash Flow | -88.49 | 18.68 | 18.31 | 80.16 | -41.35 | 244.88 |
Free Cash Flow | -64.97 | -5.83 | 348.5 | 4.37 | -144.39 | 64.94 |
Free Cash Flow Growth | - | - | 7880.00% | - | - | -9.35% |
Free Cash Flow Margin | -2.16% | -0.19% | 11.89% | 0.16% | -6.21% | 3.99% |
Free Cash Flow Per Share | -0.13 | -0.01 | 0.71 | 0.01 | -0.31 | 0.14 |
Cash Income Tax Paid | 302.74 | 298.6 | 305.02 | 302.22 | 243.22 | 188.16 |
Levered Free Cash Flow | -239.7 | -237.68 | 77.03 | -254.91 | -323.85 | 0.51 |
Unlevered Free Cash Flow | -228.19 | -228.31 | 88.67 | -248 | -312.34 | 10.52 |
Change in Working Capital | -1.44 | -1.44 | 116.67 | -34.99 | -97.14 | -103.15 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.